BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196905. A total of 4 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,643,000 | +155.3% | 24,100 | +145.9% | 0.00% | +100.0% |
| Q2 2022 | $1,427,000 | +150.8% | 9,800 | +104.2% | 0.00% | +100.0% |
| Q1 2022 | $569,000 | -32.3% | 4,800 | -21.3% | 0.00% | 0.0% |
| Q4 2021 | $840,000 | -20.5% | 6,100 | -42.5% | 0.00% | 0.0% |
| Q3 2021 | $1,056,000 | +2.6% | 10,600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,029,000 | +243.0% | 10,600 | +23990.9% | 0.00% | 0.0% |
| Q1 2021 | $300,000 | -82.7% | 44 | -78.2% | 0.00% | -50.0% |
| Q4 2020 | $1,731,000 | +158.7% | 202 | +96.1% | 0.00% | +100.0% |
| Q3 2020 | $669,000 | -72.8% | 103 | -69.4% | 0.00% | -75.0% |
| Q2 2020 | $2,463,000 | -20.3% | 337 | -62.9% | 0.00% | -20.0% |
| Q1 2020 | $3,089,000 | +86.8% | 908 | +198.7% | 0.01% | +25.0% |
| Q4 2019 | $1,654,000 | -29.9% | 304 | -46.3% | 0.00% | -42.9% |
| Q3 2019 | $2,361,000 | +225.2% | 566 | +241.0% | 0.01% | +250.0% |
| Q2 2019 | $726,000 | +244.1% | 166 | +304.9% | 0.00% | +100.0% |
| Q1 2019 | $211,000 | +627.6% | 41 | +412.5% | 0.00% | – |
| Q4 2018 | $29,000 | +866.7% | 8 | +700.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -25.0% | 1 | -99.5% | 0.00% | – |
| Q1 2018 | $4,000 | – | 214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 156 | $421,000 | 0.06% |